
The official advocacy organization for pharmacist women in the United States
Pharmacist Moms Group™

45,000+ Members

Over 6 Million posts, comments and reactions in 2020

60,000+ Followers on social media platforms
The Largest Community of Women Pharmacists in the US

Founded in 2017, Pharmacists Moms Group was created to provide women pharmacists the opportunity to network, collaborate and offer genuine feedback in a closed-door, trusted setting. The organization has quickly grown to over 45,000 members and 60,000 followers on our social media platforms.

While we may not be able to control what happens to us, we can ALWAYS control how we respond. Working on self-awareness and self-improvement will certainly create positive habits to help you when you are stuck.

Read on to learn more about Jennifer’s path to pharmacy ownership, and to learn how COVID-19 and the Oregon wildfires have impacted her business.

Miss America 2020, Camille Schrier, has been a proud, self-described “science nerd” for as long as she can remember. We caught up with Camille to get a student’s perspective on the future of the profession.

PCOS becomes PMOS, spotlighting metabolic and endocrine risks.

Be confident that you have researched all avenues and feel secure in making your recommendations.

Veligrotug-vvze is the first FDA-approved thyroid eye disease treatment with data in both active and chronic disease.

A combination regimen of zacitidine, venetoclax, and gilteritinib shows encouraging benefits in patients with newly diagnosed FLT3-mutated AML who were ineligible for intensive chemotherapy.

A compliance expert outlines what's next for GLP-1 compounding oversight and how pharmacists can stay audit-ready.

Welcome back to another Pharmacy Times Practice Pearls series. In this episode titled, 'Transitions of Care in Multiple Myeloma: Why Handoffs Remain the Biggest Operational Challenge,' Zahra Mahmoudjafari led the conversation about the following question: 1. Transitions of care has emerged as the single most consistent operational challenge, outranking efficacy and safety concerns. Why is this difficult, and where are the pain points?






.png)



